Cargando…
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
MiR-375 is a tumor suppressor miRNA that is downregulated in hepatocellular carcinoma (HCC). However, due to the lack of effective delivery strategies, miR-375 replacement as a therapy for HCC has not been investigated. In the present study, we have developed a straightforward strategy to deliver mi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349944/ https://www.ncbi.nlm.nih.gov/pubmed/27880727 http://dx.doi.org/10.18632/oncotarget.13431 |
_version_ | 1782514566633095168 |
---|---|
author | Xue, Hui-Ying Liu, Yong Liao, Jia-Zhi Lin, Ju-Sheng Li, Bin Yuan, Wei-Gang Lee, Robert J. Li, Lei Xu, Chuan-Rui He, Xing-Xing |
author_facet | Xue, Hui-Ying Liu, Yong Liao, Jia-Zhi Lin, Ju-Sheng Li, Bin Yuan, Wei-Gang Lee, Robert J. Li, Lei Xu, Chuan-Rui He, Xing-Xing |
author_sort | Xue, Hui-Ying |
collection | PubMed |
description | MiR-375 is a tumor suppressor miRNA that is downregulated in hepatocellular carcinoma (HCC). However, due to the lack of effective delivery strategies, miR-375 replacement as a therapy for HCC has not been investigated. In the present study, we have developed a straightforward strategy to deliver miR-375 into HCC cells by assembling miR-375 mimics on the surface of AuNPs and forming AuNP-miR-375 nanoparticles. AuNP-miR-375 exhibits high cellular uptake and preserves miR-375′s activities to suppress cellular proliferation, migration/invasion, and colony formation, and to induce apoptosis in HCC cells. Furthermore, AuNP-delivered miR-375 efficiently downregulated its target genes through RNA interference. In primary and xenograft tumor mouse models, AuNP-miR-375 showed high tumor uptake, therapeutic efficacy, and no apparent toxicity to the host mice. In conclusion, our findings indicate that AuNPs is a reliable strategy to deliver miR-375 into HCC cells and tissue, and that AuNP-miR-375 has the potential in the clinic for treatment of unresectable HCC. |
format | Online Article Text |
id | pubmed-5349944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53499442017-04-06 Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma Xue, Hui-Ying Liu, Yong Liao, Jia-Zhi Lin, Ju-Sheng Li, Bin Yuan, Wei-Gang Lee, Robert J. Li, Lei Xu, Chuan-Rui He, Xing-Xing Oncotarget Research Paper MiR-375 is a tumor suppressor miRNA that is downregulated in hepatocellular carcinoma (HCC). However, due to the lack of effective delivery strategies, miR-375 replacement as a therapy for HCC has not been investigated. In the present study, we have developed a straightforward strategy to deliver miR-375 into HCC cells by assembling miR-375 mimics on the surface of AuNPs and forming AuNP-miR-375 nanoparticles. AuNP-miR-375 exhibits high cellular uptake and preserves miR-375′s activities to suppress cellular proliferation, migration/invasion, and colony formation, and to induce apoptosis in HCC cells. Furthermore, AuNP-delivered miR-375 efficiently downregulated its target genes through RNA interference. In primary and xenograft tumor mouse models, AuNP-miR-375 showed high tumor uptake, therapeutic efficacy, and no apparent toxicity to the host mice. In conclusion, our findings indicate that AuNPs is a reliable strategy to deliver miR-375 into HCC cells and tissue, and that AuNP-miR-375 has the potential in the clinic for treatment of unresectable HCC. Impact Journals LLC 2016-11-17 /pmc/articles/PMC5349944/ /pubmed/27880727 http://dx.doi.org/10.18632/oncotarget.13431 Text en Copyright: © 2016 Xue et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Xue, Hui-Ying Liu, Yong Liao, Jia-Zhi Lin, Ju-Sheng Li, Bin Yuan, Wei-Gang Lee, Robert J. Li, Lei Xu, Chuan-Rui He, Xing-Xing Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma |
title | Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma |
title_full | Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma |
title_fullStr | Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma |
title_full_unstemmed | Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma |
title_short | Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma |
title_sort | gold nanoparticles delivered mir-375 for treatment of hepatocellular carcinoma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349944/ https://www.ncbi.nlm.nih.gov/pubmed/27880727 http://dx.doi.org/10.18632/oncotarget.13431 |
work_keys_str_mv | AT xuehuiying goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma AT liuyong goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma AT liaojiazhi goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma AT linjusheng goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma AT libin goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma AT yuanweigang goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma AT leerobertj goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma AT lilei goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma AT xuchuanrui goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma AT hexingxing goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma |